RxDoctor Payments Data

Edward Chaum, MD

Ophthalmology · Nashville, TNNPI 1023075868

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $154,466 of the $157,512 with a category attached, or 98.1%. Baxter Healthcare accounts for 75.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $75,660 and has fallen 99.5% since, to $375 in 2024. Among ophthalmology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$157,512in general payments, 2019–2025

Across 80 payments — averaging $1968.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$120K
  • Welch Allyn$38K
  • Regeneron Healthcare Solutions, Inc.$108
  • Spark Therapeutics, Inc.$106
$45,858in research payments, 2019–2025

Across 2 payments — averaging $22,929 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$46K

What the payments were for

  • Consulting fees$154,46698%
  • Speaking & faculty fees$2,1501%
  • Travel & lodging$4510%
  • Food & beverage$4460%

General payments by program year

19
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$157,512 in reported general payments places this provider in the 95th percentile of 323 ophthalmology providers in Tennessee.

See all ophthalmology providers in Tennessee

Medicare billing

Part B allowed, 2024
$118,854
Medicare patients
321
Services billed
1,075

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketorolac Tromethamine33$1,340
Atropine Sulfate21$872

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →